Asian Self-Monitoring Blood Glucose (SMBG) Devices Market Is Expected to Witness the Fastest Growth (6.2% CAGR) Globally during 2015 – 2022

The global market of self-monitoring blood glucose devices was valued at $11,171.1 million in 2014, and it is expected to grow with a CAGR of 5.7% during 2015 - 2022. The global market is growing, due to increasing geriatric population and increasing prevalence of diabetes. In addition, the increase in obese population and increasing awareness about diabetes care is also contributing to the growth of the market. Furthermore, technological advancements in self-monitoring blood glucose devices and growing health insurance and reimbursements policies worldwide are also encouraging the growth of the self-monitoring blood glucose devices market.

Based on type, the strips segment had the largest market in the global SMBG devices market in 2014; and it is expected to witness the fastest growth with 5.7% CAGR during 2015 – 2022.

Browse Report Description with Detailed TOC on “SMBG Devices Market” at: www.psmarketresearch.com/market-analysis/self-monitoring-blood-glucose-market

The Changes in lifestyle, with increased consumption of alcohol, tobacco, odd sleeping hours, and consumption of junk food leads to diabetes. The growing prevalence of diabetes, along with the increasing awareness due to health education further supports the growth of the global self-monitoring blood glucose devices market.

Browse Report Sample at: www.psmarketresearch.com/market-analysis/self-monitoring-blood-glucose-market/report-sample

Aging population acts as a major growth driver for the global SMBG devices market, as old age is associated with loss of mobility, low fluid intake, poor food intake, and sleep disturbances. In addition, with aging the body of a person becomes weak and susceptible to various other illnesses, thus leading to consumption of drugs affecting the digesting system resulting in diabetes. This fuels the demand for self-monitoring blood glucose devices market.

However, the product recall and availability of continuous glucose monitors to diagnose and monitor the glucose levels in diabetes patients hampers the growth of the global SMBG devices market. The Asian market is expected to witness fastest growth, with a CAGR of 6.2% during 2015 – 2022.

The key companies operating in the global self-monitoring blood glucose devices market include Medtronic Inc., Abbott Laboratories Inc., Hoffmann-La Roche Ltd., Bayer AG , Life Scan Inc.(J&J), B. Braun Melsungen AG, Nipro Diagnostics Inc., Arkray Devices, Nova Biomedical, and Bionime corporation.

Browse Related Research at: www.psmarketresearch.com/industry-report/medical-devices

GLOBAL SMBG DEVICES MARKET SEGMENTATION
By Type
 Strips
 Glucose Meter
 Lancets
 Others
By Geography
 North America- The U.S., Canada, and Rest of North America
 Europe- Germany, France, The U.K., Italy, Spain, Russia and Rest of Europe
 Asia- China, Japan, India and Rest of Asia
 Rest of the World (RoW)- Brazil and Australia

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
Deep
Assistant – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

347 5th Ave. #1402- 210
New York City
United States

This release was published on openPR.